Wellington Management Group
VYGR icon

Wellington Management Group’s Voyager Therapeutics VYGR Stock Holding History

Wellington Management Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-253,314
Closed -$856K – 2061
2025
Q1 		$856K Sell
253,314
-7,937
-3% -$37.1K ﹤0.01% 1738
2024
Q4 		$1.48M Buy
261,251
+31,882
+14% +$206K ﹤0.01% 1645
2024
Q3 		$1.34M Sell
229,369
-17,623
-7% -$128K ﹤0.01% 1660
2024
Q2 		$1.95M Buy
246,992
+42,963
+21% +$360K ﹤0.01% 1517
2024
Q1 		$1.9M Buy
+204,029
New +$1.72M ﹤0.01% 1532
2023
Q4 		– Sell
-84,619
Closed -$656K – 1935
2023
Q3 		$656K Buy
84,619
+4,033
+5% +$36.8K ﹤0.01% 1664
2023
Q2 		$923K Buy
+80,586
New +$834K ﹤0.01% 1616
2020
Q4 		– Sell
-347,115
Closed -$3.7M – 2020
2020
Q3 		$3.7M Sell
347,115
-81,047
-19% -$951K ﹤0.01% 1321
2020
Q2 		$5.4M Sell
428,162
-28,861
-6% -$336K ﹤0.01% 1199
2020
Q1 		$4.18M Sell
457,023
-21,973
-5% -$252K ﹤0.01% 1230
2019
Q4 		$6.68M Hold
478,996
– – ﹤0.01% 1265
2019
Q3 		$8.24M Sell
478,996
-13,200
-3% -$277K ﹤0.01% 1222
2019
Q2 		$13.4M Hold
492,196
– – ﹤0.01% 1118
2019
Q1 		$9.42M Hold
492,196
– – ﹤0.01% 1222
2018
Q4 		$4.63M Sell
492,196
-22,679
-4% -$291K ﹤0.01% 1409
2018
Q3 		$9.74M Sell
514,875
-3,479
-0.7% -$66.8K ﹤0.01% 1289
2018
Q2 		$10.1M Buy
518,354
+18,344
+4% +$363K ﹤0.01% 1278
2018
Q1 		$9.39M Buy
500,010
+305,193
+157% +$6.6M ﹤0.01% 1294
2017
Q4 		$3.23M Sell
194,817
-4,960
-2% -$85K ﹤0.01% 1603
2017
Q3 		$4.11M Buy
199,777
+16,540
+9% +$187K ﹤0.01% 1527
2017
Q2 		$1.64M Buy
183,237
+51,925
+40% +$523K ﹤0.01% 1751
2017
Q1 		$1.74M Buy
131,312
+19,450
+17% +$236K ﹤0.01% 1774
2016
Q4 		$1.43M Sell
111,862
-11,950
-10% -$153K ﹤0.01% 1778
2016
Q3 		$1.49M Hold
123,812
– – ﹤0.01% 1739
2016
Q2 		$1.36M Sell
123,812
-830,328
-87% -$10.2M ﹤0.01% 1709
2016
Q1 		$8.33M Sell
954,140
-516,448
-35% -$5.86M ﹤0.01% 1206
2015
Q4 		$32.1M Buy
+1,470,588
New +$33.9M 0.01% 813

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's VYGR Position: Q2 2025 in Review

Wellington Management Group sold out of Voyager Therapeutics (VYGR) in Q2 2025, closing a stake of 253,314 shares — an estimated $856K sold.

Wellington Management Group first reported a position in VYGR in Q4 2015 and held it in 27 quarters. The position peaked at $32.1M in Q4 2015. 112 funds tracked by Wall St. Rank hold VYGR as of Q2 2025.

  • Wellington Management Group reported no remaining Voyager Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Wellington Management Group sold 253,314 Voyager Therapeutics shares in Q2 2025, an estimated $856K.
  • Wellington Management Group first reported a position in Voyager Therapeutics in Q4 2015 and held it in 27 quarters.
  • Wellington Management Group's Voyager Therapeutics position peaked at $32.1M in Q4 2015.
  • 112 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2025.

Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.